Gilead Sciences (GILD) on Watch Following CMS Blog Post

November 14, 2016 2:07 PM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Gilead Sciences (NASDAQ: GILD) was in focus after it was mentioned in a CMS blog post discussing the increase in costs of prescription drugs.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment